Adial Pharmaceuticals (ADIL) Q1 2026 Earnings

6MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-3.5
-2.39
-1.29
-0.18

Details

Expected EPS
-2.13
Actual EPS
-1.81
Surprise EPS
0.32
Surprise Percent
+15.02%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -1.81 per share for Q1 2026.

0 Comments

Share your thoughts